What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Ankyra Therapeutics’ cANK-101 delivers promising preliminary data in canine melanoma trial Ankyra Therapeutics, a biotech innovator, unveiled groundbreaking preliminary results from their exploratory Phase 1 canine clinical trial today.… byPallavi MadhirajuOctober 15, 2023